#European cannabis
#European cannabis · page 12
- Pharmaceutical
Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach
THE Chairman of a recently-listed UK pharmaceutically-focused cannabis company has stood down after a breach of market rules.
- Press releases
Aurora Cannabis Acquires Significant Equity Stake In Growery BV – One Of 10 Successful Applicants For A Cannabis Production Licence In The Netherlands
Aurora Cannabis Inc (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Aurora Nederland B.V., a wholly owned indirect subsidiary of the Company, has entered into an agreement to invest in a significant equity stake in Netherlands-based Growery B.V. one of the few license holders entitled to participate in the Controlled…
- News
Portuguese Firm Atann Helps De-Risk Supply Chain Market Entry With ‘One-Stop Shop’
ATANN, a Portuguese company founded in May last year, is poised to become the country’s first cannabis contract manufacturer.
- Press releases
Pharma C Invests In Product Earth Expo
Pharma C Investments (AQSE: PCIL), an early-stage investor and venture builder in the medical cannabis industry with a particular focus on ancillary businesses, is pleased to announce that it has completed its first investment in a company called Product Earth Expo UK Limited (“Product Earth”).
- Medical
Cannabis Company’s Buy And Build Strategy Boosted By High Profile Investor Support
AFTER recently announcing billionaire investor Christian Angermayer had become its largest shareholder German cannabis company SynBiotic has secured a further €7m to fuel its rapid expansion plans.
- Press releases
Creso Pharma To Expand Into Burgeoning Swiss Medicinal Cannabis Market
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has launched efforts to enter the expanding Swiss cannabis market, with a non-binding Letter of Intent (LOI) forming the first overture to Innuana AG Switzerland, a local licensed cannabis grower, to grow and market medicinal cannabis in the Swiss market on Creso’s behalf.
- Medical
Heath Minister Says Lack Of UK Medical Cannabis Scripts Is a Clinical Issue – Not A Political One
DESPITE coming under increasing pressure to unblock the medical cannabis prescribing impasse the UK Government this week continued to distance itself from the issue.
- CBD Market
Europe’s Smaller Hemp Farms Face a ‘Grim Outlook’ For 2022, Finds Survey
HIGHER energy costs, staff shortages and Covid-induced supply chain issues have left Europe’s hemp farmers feeling the pinch, finds a new market report.
- CBD Market
CBD Business Love Hemp To List On The London Stock Exchange Within The Next Few Months
LOVE Hemp Group informed its investors this week that its upcoming admission to the London Stock Exchange’s (LSE) is “imminent”.
- CBD Market
Europe Must Dismiss INCB’s Efforts To Classify CBD A Narcotic Drug, Says KanaVape Co-Founder
KanaVape co-founder Sébastien Béguerie takes issue with potentially damaging Cannabis Initiative from the International Narcotics Control Board and the influence it may have on the European Union’s position on CBD.
- News
Huge Increase In UK Cannabis Motoring Convictions Highlights Pressing Need For Law Change
A CAMPAIGN group is calling for a review of the way drug driving is tackled and a return to pre-2015 legislation following a dramatic increase in the number of cannabis users convicted since the law was changed six years ago.
- Pharmaceutical
UK Cannabis Company’s C-Suite Left ‘Shaking Their Heads’ In Disbelief At Company’s Poor Stock Performance
FOLLOWING its listing on the London Stock Exchange in May this year Oxford Cannabinoid Technologies (OCT) has seen more than £20m wiped off its market capitalisation.
